These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37933217)

  • 1. Enhancing Opiorphin's Metabolic Stability and Preserving its Potent Analgesic Effect: A Systematic Review.
    Tome J; Ibrahim MN; Cowan LT
    Curr Top Med Chem; 2024; 24(1):74-88. PubMed ID: 37933217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STR-324, a Stable Analog of Opiorphin, Causes Analgesia in Postoperative Pain by Activating Endogenous Opioid Receptor-dependent Pathways.
    Sitbon P; Van Elstraete A; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
    Anesthesiology; 2016 Nov; 125(5):1017-1029. PubMed ID: 27571257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically active human opiorphin is a potent yet non-addictive analgesic without drug tolerance effects.
    Rougeot C; Robert F; Menz L; Bisson JF; Messaoudi M
    J Physiol Pharmacol; 2010 Aug; 61(4):483-90. PubMed ID: 20814077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management.
    Mennini N; Mura P; Nativi C; Richichi B; Di Cesare Mannelli L; Ghelardini C
    Future Sci OA; 2015 Nov; 1(3):FSO2. PubMed ID: 28031877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice.
    Tian XZ; Chen J; Xiong W; He T; Chen Q
    Peptides; 2009 Jul; 30(7):1348-54. PubMed ID: 19442408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice.
    Popik P; Kamysz E; Kreczko J; Wróbel M
    Behav Brain Res; 2010 Nov; 213(1):88-93. PubMed ID: 20438769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiorphin analysis in equine plasma and urine using hydrophilic interaction LC-MS.
    Wang CC; Hartmann-Fischbach P; Krueger TR; Wells TL; Simonson A; Compton JC
    Bioanalysis; 2015; 7(5):593-603. PubMed ID: 25826141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of electroencephalographic changes in response to acute electrical and thermal stimuli with the tail flick and hot plate test in rats administered with opiorphin.
    Singh P; Kongara K; Harding D; Ward N; Dukkipati VSR; Johnson C; Chambers P
    BMC Neurol; 2018 Apr; 18(1):43. PubMed ID: 29673329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.
    Wisner A; Dufour E; Messaoudi M; Nejdi A; Marcel A; Ungeheuer MN; Rougeot C
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17979-84. PubMed ID: 17101991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of synthetic analogues of human opiorphin on rat brain opioid receptors.
    Benyhe Z; Toth G; Wollemann M; Borsodi A; Helyes Z; Rougeot C; Benyhe S
    J Physiol Pharmacol; 2014 Aug; 65(4):525-30. PubMed ID: 25179084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
    Mura P; Mennini N; Nativi C; Richichi B
    Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum.
    Kamysz E; Sałaga M; Sobczak M; Kamysz W; Fichna J
    J Pept Sci; 2013 Mar; 19(3):166-72. PubMed ID: 23381913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Opiorphin Analog STR-324 Decreases Sensory Hypersensitivity in a Rat Model of Neuropathic Pain.
    Van Elstraete A; Sitbon P; Hamdi L; Juarez-Perez V; Mazoit JX; Benhamou D; Rougeot C
    Anesth Analg; 2018 Jun; 126(6):2102-2111. PubMed ID: 28806211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endomorphin-2 analogs with C-terminal esterification produce potent systemic antinociception with reduced tolerance and gastrointestinal side effects.
    Wang CL; Qiu TT; Yang DJ; Yuan BY; Han FT; Li L; Gu N
    Neuropharmacology; 2017 Apr; 116():98-109. PubMed ID: 28042019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of polar side chains modifications on the dual enkephalinase inhibitory activity and conformation of human opiorphin, a pain perception related peptide.
    Rosa M; Marcelo F; Calle LP; Rougeot C; Jiménez-Barbero J; Arsequell G; Valencia G
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5190-3. PubMed ID: 26463133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiorphin in burning mouth syndrome patients: a case-control study.
    Salarić I; Sabalić M; Alajbeg I
    Clin Oral Investig; 2017 Sep; 21(7):2363-2370. PubMed ID: 28013436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of opiorphin, sialorphin and their conjugates with a peptide klaklakklaklak.
    Kamysz E; Smolarczyk R; Cichoń T; Jarosz-Biej M; Sikorska E; Sobocińska M; Jaśkiewicz M; Kamysz W
    J Pept Sci; 2016 Nov; 22(11-12):723-730. PubMed ID: 27862720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of opiorphin through a blood-brain barrier culture model.
    Bocsik A; Darula Z; Tóth G; Deli MA; Wollemann M
    Arch Med Res; 2015 Aug; 46(6):502-6. PubMed ID: 26143971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphin-1 analogs with oligoarginine-conjugation at C-terminus produce potent antinociception with reduced opioid tolerance in paw withdrawal test.
    Yuan BY; Liu WZ; Wang XF; Zhang YZ; Yang DJ; Wang CL
    Peptides; 2018 Aug; 106():96-101. PubMed ID: 30016700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B2-kinin receptors in the dorsal periaqueductal gray are implicated in the panicolytic-like effect of opiorphin.
    Sestile CC; Maraschin JC; Rangel MP; Santana RG; Zangrossi H; Graeff FG; Audi EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):493-498. PubMed ID: 28797641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.